231 related articles for article (PubMed ID: 30021656)
1. Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis.
Gao W; Guo N; Dong T
World J Surg Oncol; 2018 Jul; 16(1):145. PubMed ID: 30021656
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
5. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
Zong R; Ma X; Shi Y; Geng L
Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
Li B; Li Q; Chen C; Guan Y; Liu S
Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
[TBL] [Abstract][Full Text] [Related]
7. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
[TBL] [Abstract][Full Text] [Related]
8. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
[TBL] [Abstract][Full Text] [Related]
9. Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
Gu YL; Pan SM; Ren J; Yang ZX; Jiang GQ
Clin Breast Cancer; 2017 Jul; 17(4):245-255. PubMed ID: 28209330
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.
Li B; Li Q; Nie W; Liu S
Eur J Radiol; 2014 Feb; 83(2):338-44. PubMed ID: 24355655
[TBL] [Abstract][Full Text] [Related]
12. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of high b-value diffusion-weighted MRI for prostate cancer detection: a meta-analysis.
Godley KC; Syer TJ; Toms AP; Smith TO; Johnson G; Cameron D; Malcolm PN
Acta Radiol; 2018 Jan; 59(1):105-113. PubMed ID: 28376634
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis on the diagnostic value of laser Doppler imaging for burn depth].
Huang Y; Qiu L; Mei AL; Li JX
Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):301-308. PubMed ID: 28651422
[No Abstract] [Full Text] [Related]
16. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
Guo C; Zhang C; Liu J; Tong L; Huang G
Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
[TBL] [Abstract][Full Text] [Related]
17. Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy.
Leong KM; Lau P; Ramadan S
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):268-77. PubMed ID: 25913106
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
Du X; He Y; Lin W
Front Neurol; 2022; 13():882334. PubMed ID: 35812103
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of diffusion-weighted imaging in the differential diagnosis of renal lesions.
Li Y; Wang Y; Qin J; Wu J; Dai X; Xu J
Clin Imaging; 2018; 52():264-272. PubMed ID: 30172176
[TBL] [Abstract][Full Text] [Related]
20. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
